Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.16B |
| 2 |
Hershey
HSY
|
+$663M |
| 3 |
Lockheed Martin
LMT
|
+$622M |
| 4 |
Altria Group
MO
|
+$525M |
| 5 |
Pfizer
PFE
|
+$499M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.76B |
| 2 |
Merck
MRK
|
+$2.35B |
| 3 |
Automatic Data Processing
ADP
|
+$1.57B |
| 4 |
Blackstone
BX
|
+$1.38B |
| 5 |
Illinois Tool Works
ITW
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.85% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.72% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Ferrari
RACE
$70.5B
| $2.54M | ﹤0.01% |
5,834
+1,429
| +32% | +$554K |
|
|
AGS
2527
DELISTED
PlayAGS
AGS
| $2.53M | ﹤0.01% |
282,014
+48,426
| +21% | +$423K |
|
2528
Daktronics
DAKT
$1,000M
| $2.53M | ﹤0.01% |
253,887
+107,094
| +73% | +$893K |
|
2529
Aspen Aerogels
ASPN
$392M
| $2.52M | ﹤0.01% |
143,351
-3,391
| -2% | -$50K |
|
2530
Rio Tinto
RIO
$156B
| $2.52M | ﹤0.01% |
39,568
+268
| +0.7% | +$17.9K |
|
2531
Target Hospitality
TH
$1.57B
| $2.52M | ﹤0.01% |
231,966
+7,938
| +4% | +$74.5K |
|
2532
PetMed Express
PETS
$42.3M
| $2.51M | ﹤0.01% |
522,965
+96,014
| +22% | +$558K |
|
|
NPKI
2533
NPK International
NPKI
$1.12B
| $2.5M | ﹤0.01% |
346,523
+137,288
| +66% | +$897K |
|
2534
Tyra Biosciences
TYRA
$1.91B
| $2.5M | ﹤0.01% |
152,212
+41,675
| +38% | +$683K |
|
2535
Atea Pharmaceuticals
AVIR
$369M
| $2.47M | ﹤0.01% |
612,319
+27,993
| +5% | +$110K |
|
2536
Clover Health Investments
CLOV
$2.28B
| $2.46M | ﹤0.01% |
3,094,125
+1,375,395
| +80% | +$1.25M |
|
2537
British American Tobacco
BTI
$128B
| $2.44M | ﹤0.01% |
80,047
+57,999
| +263% | +$1.75M |
|
2538
MBIA
MBI
$266M
| $2.43M | ﹤0.01% |
359,498
-406,247
| -53% | -$2.57M |
|
2539
NextNav
NN
$1.81B
| $2.41M | ﹤0.01% |
366,800
+5,372
| +1% | +$23.9K |
|
2540
Westrock Coffee
WEST
$807M
| $2.41M | ﹤0.01% |
233,057
-3,467
| -1% | -$35K |
|
|
AMPS
2541
DELISTED
Altus Power
AMPS
| $2.4M | ﹤0.01% |
502,175
+5,287
| +1% | +$31.5K |
|
2542
Qfin Holdings
QFIN
$1.69B
| $2.4M | ﹤0.01% |
130,236
-20,405
| -14% | -$320K |
|
2543
Qiagen
QGEN
$8.73B
| $2.38M | ﹤0.01% |
53,932
+1,645
| +3% | +$75K |
|
2544
Vanguard Morningstar Mega Cap Growth ETF
MGK
$33.2B
| $2.37M | ﹤0.01% |
41,315
-4,105
| -9% | -$226K |
|
2545
ALX Oncology
ALXO
$260M
| $2.34M | ﹤0.01% |
209,759
+1,595
| +0.8% | +$22.4K |
|
2546
Allient
ALNT
$1.53B
| $2.33M | ﹤0.01% |
65,409
-903
| -1% | -$27K |
|
2547
iQIYI
IQ
$1.26B
| $2.31M | ﹤0.01% |
547,175
| – | – |
|
2548
Honda
HMC
$38.4B
| $2.31M | ﹤0.01% |
62,091
+17,999
| +41% | +$618K |
|
|
SLRN
2549
DELISTED
ACELYRIN
SLRN
| $2.3M | ﹤0.01% |
340,871
+93,115
| +38% | +$707K |
|
2550
Financial Institutions
FISI
$838M
| $2.3M | ﹤0.01% |
121,952
+2,350
| +2% | +$46.5K |
|
Similar funds
Charles Schwab's Q1 2024 Portfolio in Review
As of Q1 2024, Charles Schwab held 3,573 positions worth $433B, up 10% from $394B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3.8%. Charles Schwab opened 35 new positions and exited 102, leaving the 3,573-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2024 buy was Schwab Fundamental US Large Company Index ETF: 3,608,604 shares worth $81.1M.
- Charles Schwab added most to Bristol-Myers Squibb in Q1 2024, an estimated $2.16B increase.
- Charles Schwab's biggest Q1 2024 reduction was Broadcom, cutting an estimated $2.76B.
- Charles Schwab fully exited Splunk Inc in Q1 2024, selling an estimated $104M.
- Charles Schwab's ten largest holdings make up 20% of its $433B portfolio in Q1 2024.
- Charles Schwab opened 35 new positions and closed 102 in Q1 2024.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $433B.
Based on Charles Schwab's 13F filing for Q1 2024, filed 9 May 2024.